Nahid Eskandari
- Molecular Biology
- Immunology top 5%
- Cancer Research top 10%
- Oncology
- Epidemiology
- Co-authors
- Mazdak Ganjalıkhani-HakemiMorteza JafariniaZahra YousefiFarshid FathiNarges EbrahimiGholamreza KhosraviHossein MotedayyenFereshteh Alsahebfosoul
- Topics
- Multiple Sclerosis Research Studies (13 papers)Asthma and respiratory diseases (11 papers)MicroRNA in disease regulation (9 papers)
- Journals
- SHILAP Revista de lepidopterologíaBritish Journal of PharmacologyFrontiers in Immunology
- Partner nations
- IranUnited KingdomUnited States
In The Last Decade
Nahid Eskandari
98 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Molecular Biology 656
- Immunology 480
- Cancer Research 270
- Oncology 222
- Epidemiology 197
Countries citing papers authored by Nahid Eskandari
This map shows the geographic impact of Nahid Eskandari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nahid Eskandari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nahid Eskandari more than expected).
Fields of papers citing papers by Nahid Eskandari
This network shows the impact of papers produced by Nahid Eskandari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nahid Eskandari. The network helps show where Nahid Eskandari may publish in the future.
Co-authorship network of co-authors of Nahid Eskandari
This figure shows the co-authorship network connecting the top 25 collaborators of Nahid Eskandari. A scholar is included among the top collaborators of Nahid Eskandari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nahid Eskandari. Nahid Eskandari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Immunologic tumor microenvironment modulators for turning cold tumors hotbreakdown → | 137 |
| 2 | 0 | |
| 3 | 7 | |
| 4 | 3 | |
| 5 | 4 | |
| 6 | 6 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 6 | |
| 10 | 79 | |
| 11 | 66 | |
| 12 | 13 | |
| 13 | 2 | |
| 14 | 19 | |
| 15 | 3 | |
| 16 | 1 | |
| 17 | 40 | |
| 18 | 16 | |
| 19 | 3 | |
| 20 | 10 |
About Nahid Eskandari
Nahid Eskandari is a scholar working on Immunology, Immunology and Allergy and Pathology and Forensic Medicine, having authored 101 papers that have together received 1.6k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (13 papers), Asthma and respiratory diseases (11 papers) and MicroRNA in disease regulation (9 papers). The work is most often cited by research in Immunology (480 citations), Cancer Research (270 citations) and Immunology and Allergy (71 citations). Nahid Eskandari has collaborated with scholars based in Iran, United Kingdom and United States. Frequent co-authors include Mazdak Ganjalıkhani-Hakemi, Morteza Jafarinia, Zahra Yousefi, Farshid Fathi, Narges Ebrahimi, Gholamreza Khosravi, Hossein Motedayyen, Fereshteh Alsahebfosoul, Hossein Salehi and Mohammad Esmaeil Akbari. Their work appears in journals such as SHILAP Revista de lepidopterología, British Journal of Pharmacology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.